Lyra TherapeuticsLYRA

13F holders, Q4 2024 (December 31)
54holders −8
7new positions
15sold out
1famous investor
$0.21avg. 13F price*

At the end of Q4 2024, 54 institutions reported holding Lyra Therapeutics Inc. (LYRA) in their 13F filings, down 8 from Q3 2024. 7 opened new positions and 15 sold out. The largest holders were Perceptive Advisors LLC ($2.6M), BlackRock, Inc. ($642K) and Samsara Biocapital, LLC ($406K). One famous investor held it Cliff Asness (0.0% of AQR Capital Management's portfolio).

Company
Lyra Therapeutics Inc.
CUSIP
55234L105
Latest filing quarter
Q2 2025

History

Number of 13F holders

020406080 Q1 2024: 79Q1 2024Q2 2024: 51Q2 2024Q3 2024: 62Q3 2024Q4 2024: 54Q4 2024Q1 2025: 57Q1 2025Q2 2025: 1Q2 2025

Total Exit/New Position Q3 2024 → Q4 2024

InstitutionsTotal Value
New Positions7$247K
Exits15$1.4M

All 13F filers, Q3 2024 → Q4 2024: 2,253,812 shares bought and 7,891,013 shares sold, net −5,637,201 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 54 holders

Perceptive Advisors LLC 0.07% No change 12,757,562 $2.6M
BlackRock, Inc. 0.00% Add +3.9% 3,109,798 $642K
Samsara Biocapital, LLC 0.06% Reduce -29.3% 1,965,689 $406K
Vanguard Group Inc. 0.00% Add +0.5% 1,787,422 $368K
Ikarian Capital, LLC 0.06% Add +0.1% 1,058,148 $218K
Geode Capital Management, LLC 0.00% Add +15.3% 885,966 $183K
Goldman Sachs Group Inc. 0.00% Add +1.5% 555,508 $115K
ADAR1 Capital Management, LLC 0.02% New 533,200 $110K
State Street Corp. 0.00% No change 488,720 $101K
UBS Group AG 0.00% Add +1605.7% 424,965 $88K
Two Sigma Advisers, LP 0.00% Reduce -16.3% 385,500 $80K
Qube Research & Technologies Ltd 0.00% New 342,159 $71K
Northern Trust Corp. 0.00% Add +56.2% 286,310 $59K
BNP Paribas Financial Markets 0.00% New 244,920 $51K
Boothbay Fund Management, LLC 0.00% Add +0.6% 233,989 $48K
Morgan Stanley 0.00% Reduce -66.8% 216,485 $45K
Two Sigma Investments, LP 0.00% Reduce -25.7% 209,997 $43K
JPMorgan Chase & Co. 0.00% Add +161.8% 156,442 $32K
New York State Common Retirement Fund 0.00% No change 154,800 $32K
Charles Schwab Investment Management Inc. 0.00% No change 111,609 $23K
Susquehanna International Group, LLP 0.00% Add +701.0% 103,430 $21K
FMR LLC 0.00% Add +147.8% 99,791 $21K
Sei Investments Co. 0.00% Reduce -91.6% 84,075 $17K
Bank of New York Mellon Corp 0.00% No change 75,966 $16K
Barclays PLC 0.00% Add +18.9% 75,254 $16K
Bank of Montreal 0.00% Reduce -54.7% 54,130 $11K
Bank of America Corp. 0.00% Add +7.0% 52,664 $11K
Virtu Financial LLC 0.00% New 42,069 $9K
Rhumbline Advisers 0.00% No change 41,258 $8K
Tower Research Capital LLC (TRC) 0.00% Add +163.1% 39,785 $8K
Citigroup Inc. 0.00% Add +8.8% 38,102 $8K
SG Americas Securities, LLC 0.00% Reduce -12.4% 31,907 $7K
Alliancebernstein L.P. 0.00% No change 33,120 $7K
AQR Capital Management 0.00% Reduce -46.9% 28,713 $6K
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 0.00% Add +4.6% 27,770 $6K
Wells Fargo & Company 0.00% Add +40.6% 24,744 $5K
Corebridge Financial, Inc. 0.00% Reduce -7.0% 24,061 $5K
Invesco Ltd. 0.00% Add +4.3% 23,626 $5K
T. Rowe Price Associates Inc. 0.00% No change 17,541 $4K
Abel Hall, LLC 0.00% New 17,647 $4K
ProShare Advisors LLC 0.00% New 13,631 $3K
Royal Bank of Canada 0.00% Reduce -14.2% 5,294 $2K
Cwm, LLC 0.00% Add +628.8% 5,371 $1K
Ameritas Investment Partners, Inc. 0.00% No change 4,741 $979
SBI Securities Co., Ltd. 0.00% — 4,269 $881
California State Teachers Retirement System 0.00% No change 3,507 $724
Comerica Bank 0.00% No change 1,159 $239
Wilmington Savings Fund Society, FSB 0.00% No change 1,025 $212
Jones Financial Companies LLLP 0.00% No change 500 $103
Nisa Investment Advisors, LLC 0.00% Add +1251.3% 500 $103
EverSource Wealth Advisors, LLC 0.00% New 119 $25
Sterling Capital Management LLC 0.00% No change 88 $18
Amalgamated Bank 0.00% No change 1,674 $0
Simplex Trading, LLC 0.00% Reduce -91.3% 363 $0

"% of holder's portfolio" is LYRA's weight in each manager's 13F, not the share of Lyra Therapeutics Inc. the manager owns.